Increased prevalence of nonsteroidal anti-inflammatory drug hypersensitivity in atopic individuals [1]

Annals of Allergy, Asthma and Immunology

Volumn 97, Issue 4, 2006, Pages 557-

  Sanchez Borges, Mario ^a   Capriles, Arnaldo ^a   Caballero Fonseca, Fernan ^a  

^a Centro Medico Docente La Trinidad   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AEROALLERGEN; ALLERGEN; IMMUNOGLOBULIN E; NONSTEROID ANTIINFLAMMATORY AGENT; UNCLASSIFIED DRUG;

ALLERGIC REACTION; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARACHIDONIC ACID METABOLISM; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASPIRIN INTOLERANT ASTHMA; ASTHMA; ATOPY; CROSS REACTION; DERMATITIS; DISEASE ASSOCIATION; DRUG HYPERSENSITIVITY; FOOD ALLERGY; GENE LOCUS; GENETIC LINKAGE; GENETIC PREDISPOSITION; HLA SYSTEM; HUMAN; IMMUNOLOGY; LETTER; PREVALENCE; PRICK TEST; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RHINITIS; SKIN MANIFESTATION; URTICARIA;

EID: 33750100122     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60950-7     Document Type: Letter

References (10)

1. Kupczyk M, Kuprys I, Gorski P, Kuna P. Aspirin intolerance and allergy to house dust mites: important factors associated with development of severe asthma. Ann Allergy Asthma Immunol. 2004;92:453-458.
2. Sánchez-Borges M, Capriles-Hulett A. Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity. Ann Allergy Asthma Immunol. 2000;84:101-106.
3. Rosario NA, Ribeiro AC. Achados clínicos da sensibilidades a analgésicos e anti-inflamatorios não-hormonais. Rev Assoc Med Bras. 2000;46:201-206.
4. Quiralte J, Blanco C, Castillo R, et al. Intolerance to nonsteroidal anti-inflammatory drugs: results of controlled drug challenges in 98 patients. J Allergy Clin Immunol. 1996;98: 678-675.
5. Berges-Gimeno MP, Simon RA, Stevenson DD. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2002;89: 474-478.
6. Kemp SF, Lockey RF, Wolf BL, Lieberman P. Anaphylaxis: a review of 266 cases. Arch Intern Med. 1995;155:1749-1754.
7. Sanak M, Simon HU, Szczeklik A. Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet. 1997;350:1599-1600.
8. Choi JH, Park HS, Oh HB, et al. Leukotriene-related gene polymorphisms in Asa-intolerant asthma: an association with a haplotype of 5-lipoxygenase. Hum Genet. 2004;114:337-344.
9. Jinnai N, Sakagami T, Sekigawa T, et al. Polymorphism in the prostaglandin E2 receptor subtype 2 gene confer susceptibility to aspirin-intolerant asthma: a candidate gene approach. Hum Mol Genet. 2004;13:3203-3217.
10. Dekker JW, Nizankowska E, Schmitz-Schumann M, et al. Aspirin-induced asthma and HLA-DRB1 and HLA-DPB1 genotypes. Clin Exp Allergy. 1997;27:574-577.